Last10K.com

Accellent Corp. (1297885) SEC Filing 10-Q Quarterly report for the period ending Thursday, March 31, 2005

Accellent Corp.

CIK: 1297885

Exhibit 99.1

 

Investor Contact: Stewart A. Fisher

 

Media Contact Information: Nanette Pietroforte

EVP and CFO

 

FischerHealth, Inc.

(610) 409-2225

 

(310) 577-7870, ext. 161

stewart.fisher@accellent.com

 

npietroforte@fischerhealth.com

 

For Immediate Release

 

Medical Device Manufacturing, Inc. (now known as Accellent Corp.) Announces
First Quarter Financial Results and Name Change

 

Newton, MA. (May 4, 2005)

– Accellent Corp., formerly known as Medical Device Manufacturing, Inc. (the “Company”), a wholly owned subsidiary of Accellent Inc., announced strong results for the three months ended March 31, 2005, reflecting contributions from its acquisition of MedSource Technologies, Inc. on June 30, 2004  and continued strong organic growth.

 

First Quarter Financial Results

 

Net sales for the first quarter of 2005 increased 110% to $108.9 million compared with $51.8 million in the corresponding period of 2004.  The acquisition of MedSource contributed $45.8 million of net sales in the first quarter of 2005.  Net income for the first quarter of 2005 was $3.2 million compared to net income in the corresponding period of 2004 of $2.4 million.  Adjusted EBITDA(1) for the first quarter of 2005 was $20.0 million compared to $9.6 million in the corresponding period of 2004.  Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in the financial statements accompanying this press release.

 

Pro Forma Financial Results(2)

 

Net sales for the first quarter of 2005 increased 12% to $108.9 million compared with pro forma net sales of $97.6 million in the corresponding period of 2004, reflecting strong growth in our targeted cardiovascular, endoscopic and orthopaedic markets.  The impact of the Company’s facility rationalization program, which included the closing or selling of select facilities, negatively impacted first quarter 2005 sales by approximately 2%.

 

Adjusted EBITDA for the first quarter of 2005 increased 32% to $20.0 million versus pro forma Adjusted EBITDA of $15.2 million in the corresponding period of 2004.  Adjusted EBITDA margins for the first quarter of 2005 improved to 18.4% from pro forma Adjusted EBITDA margins of 15.6% for the corresponding period of 2004.

 

1


The following information was filed by Accellent Corp. on Wednesday, May 4, 2005 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Accellent Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accellent Corp..

Continue

Assess how Accellent Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accellent Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
CIK: 1297885
Form Type: 10-Q Quarterly Report
Accession Number: 0001047469-05-013936
Submitted to the SEC: Mon May 09 2005 2:42:03 PM EST
Accepted by the SEC: Mon May 09 2005
Period: Thursday, March 31, 2005
Industry: Surgical And Medical Instruments And Apparatus

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1297885/0001047469-05-013936.htm